Login / Signup

Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients.

Chaiho JeongHee-Je KimSeok LeeMoo Il KangJeonghoon Ha
Published in: International journal of endocrinology (2020)
Denosumab improved bone mineral density in haematopoietic stem cell transplantation recipients. The use of denosumab could be a good therapeutic option without causing severe adverse effects in recipients of haematopoietic transplantation.
Keyphrases
  • bone mineral density
  • stem cell transplantation
  • postmenopausal women
  • body composition
  • kidney transplantation
  • high dose
  • acute myeloid leukemia
  • early onset
  • stem cells
  • mesenchymal stem cells